Litigation Details for Astellas Pharma Inc. v. Aurobindo Pharma Ltd. (D. Del. 2016)
✉ Email this page to a colleague
Astellas Pharma Inc. v. Aurobindo Pharma Ltd. (D. Del. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-10-13 |
| Court | District Court, D. Delaware | Date Terminated | 2019-03-18 |
| Cause | 35:271 Patent Infringement | Assigned To | Joseph F. Bataillon |
| Jury Demand | None | Referred To | Christopher J. Burke |
| Patents | 6,346,532; 7,342,117; 7,982,049; 8,835,474; RE44,872 | ||
| Link to Docket | External link to docket | ||
Details for Astellas Pharma Inc. v. Aurobindo Pharma Ltd. (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-01-16 | 22 | belief, Aurobindo admits that U.S. Patent No. 6,346,532 (“the ’532 patent”) is listed in the Orange Book …117 patent are invalid under 35 U.S.C. §§ 102 and/or 103, at least over U.S. Patent No. 6,346,532, alone…claims of the ’117 patent are invalid as obvious over claim 6 of U.S. Patent No. 6,346,532 under the doctrine…of the ’049 patent are invalid as obvious over claim 12 of the U.S. Patent No. 6,346,532 under the doctrine…EXPERIMENTAL THERAPEUTICS 939 (2000); U.S. Patent No. 6,346,532; H.M. Dallosso et al., The Association of | External link to document | |
| 2019-03-18 | 30 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,342,117 B2; 7,982,049 B2; 8,835,474…2016 18 March 2019 1:16-cv-00942 830 Patent None District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
